Julie VanOrsdel Daves - SVP Clinical Development Oper. at DiaMedica Therapeutics Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
SVP Clinical Development Oper.
Stock Symbol
DMAC on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Julie VanOrsdel Daves since 7/7/2023

Holdings reported by Julie VanOrsdel Daves for DiaMedica Therapeutics Inc.

Class Num Shares Value Price $ Report Date Ownership Underlying Class Underlying Amount
Stock Option (right to buy) 54,000 Jun 1, 2023 Direct Common Shares
Voting Common Shares, no par value per share 0 $2.80 Jun 1, 2023 Direct

Transactions reported by Julie VanOrsdel Daves for DiaMedica Therapeutics Inc.

Sym Class Transaction % Value $ Price $ Shares Shares After Date Ownership